SCHEMBL14060017

SCHEMBL14060017

Clc1ccccc1-c1c[c]cc(N2CCCCC2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ CNR2 P34972 4/20 0.38
▸ CNR1 P21554 3/20 0.38
▸ ABCB1 P08183 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ MAOB P27338 2/20 0.38
▸ NPY5R Q15761 1/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ PRMT6 Q96LA8 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ PIK3C3 Q8NEB9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14059902 0.86 CYP1A2 (0.47) ALDH1A1CNR2CNR1LMNAMAPK1
SCHEMBL14060078 0.86 MEN1 (0.43) ALDH1A1CNR2CYP2A6LMNAMAPT
SCHEMBL27953793 0.86 CNR2 (0.52) ALDH1A1HPGDKDM4ECNR2LMNA
SCHEMBL14060873 0.83 AR (0.38) ALDH1A1KDM4ECNR2CYP2A6L3MBTL1
SCHEMBL27943401 0.79 HRH3 (0.41) CNR2CNR1L3MBTL1
SCHEMBL731058 0.78 HTR1A (0.45) ALDH1A1HPGDKDM4EL3MBTL1LMNA
SCHEMBL28698328 0.78 CNR2 (0.55) ALDH1A1HPGDKDM4ECNR2CNR1
SCHEMBL5924613 0.77 CYP2A6 (0.56) ALDH1A1HPGDCYP2A6MAOBLMNA
SCHEMBL14060321 0.74 POLB (0.44) ALDH1A1KDM4ECNR2CNR1SMN1; SMN2
SCHEMBL28809740 0.71 NOTUM (0.44) ALDH1A1KDM4ECYP2A6LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103703005-A Tricyclic inhibitors of kinases ABBOTT LAB 2014-04-02 — — CN claimed
EP-2681221-A1 TRICYCLIC INHIBITORS OF KINASES AbbVie Inc. (US) 2014-01-08 — — EP claimed
WO-2012161812-A1 TRICYCLIC INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2012-11-29 — — WO claimed
CN-103703005-A Tricyclic inhibitors of kinases ABBOTT LAB 2014-04-02 — — CN disclosed
EP-2681221-A1 TRICYCLIC INHIBITORS OF KINASES AbbVie Inc. (US) 2014-01-08 — — EP disclosed
WO-2012161812-A1 TRICYCLIC INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2012-11-29 — — WO disclosed
Send feedback